Tom Bergan
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 0.2%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 127
- Antibiotics Pharmacokinetics and Efficacy 121
-
- Antibiotic Resistance in Bacteria 57
- Co-authors
- Luís Ceze (15 shared papers)Dan Grossman (11 shared papers)Joseph Devietti (7 shared papers)R. Rohwedder (9 shared papers)Owen T. Anderson (3 shared papers)M. Kocur (2 shared papers)B Lányi (1 shared paper)Sigurður B. Þorsteinsson (10 shared papers)
- Journals
- Chemotherapy (37 papers)Infection (20 papers)Journal of Antimicrobial Chemotherapy (17 papers)Methods in microbiology (9 papers)Antimicrobial Agents and Chemotherapy (7 papers)
- Partner nations
- NorwayUnited StatesSweden
In The Last Decade
Tom Bergan
270 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 158
- Molecular Medicine 918
- Pharmacology 1.5k
- Hardware and Architecture 518
- Applied Microbiology and Biotechnology 116
- Endocrinology 280
Countries citing papers authored by Tom Bergan
This map shows the geographic impact of Tom Bergan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Bergan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Bergan more than expected).
Fields of papers citing papers by Tom Bergan
This network shows the impact of papers produced by Tom Bergan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Bergan. The network helps show where Tom Bergan may publish in the future.
Co-authors
The 25 scholars most cited alongside Tom Bergan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 296 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 172 | |
| 2 | 2010 | 157 | |
| 3 | 2010 | 135 | |
| 4 | 1981 | 123 | |
| 5 | 1987 | 110 | |
| 6 | 1988 | 104 | |
| 7 | 1978 | 102 | |
| 8 | 2010 | 94 | |
| 9 | Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses. | 1987 | 94 |
| 10 | 1990 | 84 | |
| 11 | 1986 | 75 | |
| 12 | 1982 | 69 | |
| 13 | Susceptibility testing of bacteria and fungi. Report from "the Norwegian Working Group on Antibiotics". | 1997 | 69 |
| 14 | 1974 | 65 | |
| 15 | 2011 | 64 | |
| 16 | 1978 | 60 | |
| 17 | 1971 | 59 | |
| 18 | 1990 | 57 | |
| 19 | 2000 | 55 | |
| 20 | 1988 | 54 |
About Tom Bergan
Tom Bergan is a scholar working on Pharmacology, Molecular Medicine, Molecular Biology, Epidemiology and Infectious Diseases, having authored 296 papers that have together received 4.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (121 papers), Antibiotic Resistance in Bacteria (57 papers), Drug Transport and Resistance Mechanisms (20 papers), Bacterial Identification and Susceptibility Testing (19 papers), Parallel Computing and Optimization Techniques (18 papers), Antimicrobial Resistance in Staphylococcus (18 papers), Pharmaceutical studies and practices (18 papers) and Urinary Tract Infections Management (17 papers). The work is most often cited by research in Molecular Medicine (918 citations), Pharmacology (1.5k citations), Hardware and Architecture (518 citations), Applied Microbiology and Biotechnology (116 citations) and Endocrinology (280 citations). Tom Bergan has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Luís Ceze, Dan Grossman, Joseph Devietti, R. Rohwedder, Owen T. Anderson, M. Kocur, B Lányi, Sigurður B. Þorsteinsson, Sune Thorsteinsson and E. K. Brodwall. Their work appears in journals such as Chemotherapy, Infection, Journal of Antimicrobial Chemotherapy, Methods in microbiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.